BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11805191)

  • 1. The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes.
    Hines RN; McCarver DG
    J Pharmacol Exp Ther; 2002 Feb; 300(2):355-60. PubMed ID: 11805191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms.
    McCarver DG; Hines RN
    J Pharmacol Exp Ther; 2002 Feb; 300(2):361-6. PubMed ID: 11805192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 3A: ontogeny and drug disposition.
    de Wildt SN; Kearns GL; Leeder JS; van den Anker JN
    Clin Pharmacokinet; 1999 Dec; 37(6):485-505. PubMed ID: 10628899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogeny and regulation of drug metabolism in humans. Phase I: Monooxygenases.
    Leroux JP; Cresteil T; Marie S
    Dev Pharmacol Ther; 1989; 13(2-4):63-9. PubMed ID: 2693005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ontogeny of drug metabolism enzymes and implications for adverse drug events.
    Hines RN
    Pharmacol Ther; 2008 May; 118(2):250-67. PubMed ID: 18406467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression.
    Koukouritaki SB; Simpson P; Yeung CK; Rettie AE; Hines RN
    Pediatr Res; 2002 Feb; 51(2):236-43. PubMed ID: 11809920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental expression of cytochrome P450 enzymes in human liver.
    Hakkola J; Tanaka E; Pelkonen O
    Pharmacol Toxicol; 1998 May; 82(5):209-17. PubMed ID: 9646325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of drug-metabolizing enzymes.
    Parke DV
    Biochem Soc Trans; 1983 Aug; 11(4):457-8. PubMed ID: 6617976
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of drug metabolizing enzymes in the effect and side-effect of the drugs].
    Vereczkey L; Jemnitz K; Monostory K; Veres Z; Kóbori L
    Orv Hetil; 2005 May; 146(19):947-52. PubMed ID: 15969306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human drug metabolizing enzymes. I. Oxidative enzymes].
    Vereczkey L; Monostory K; Veres Z
    Acta Pharm Hung; 1998 Sep; 68(5):276-83. PubMed ID: 9805813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug metabolism in the paediatric population and in the elderly.
    Benedetti MS; Whomsley R; Canning M
    Drug Discov Today; 2007 Aug; 12(15-16):599-610. PubMed ID: 17706541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
    Goel A; Dani V; Dhawan DK
    Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of drugs in human skin.
    Svensson CK
    Drug Metab Dispos; 2009 Feb; 37(2):247-53. PubMed ID: 19005027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental pharmacogenomics.
    Neville KA; Becker ML; Goldman JL; Kearns GL
    Paediatr Anaesth; 2011 Mar; 21(3):255-65. PubMed ID: 21320234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.
    Lim HK; Duczak N; Brougham L; Elliot M; Patel K; Chan K
    Drug Metab Dispos; 2005 Aug; 33(8):1211-9. PubMed ID: 15860655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of monoxygenases in the metabolism of drugs in the human fetus and newborn infant].
    Cresteil T; Leroux JP
    Arch Fr Pediatr; 1982; 39(7):463-70. PubMed ID: 6816186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems and perspectives of phenotyping for drug-metabolizing enzymes in man.
    Zaigler M; Tantcheva-Poór I; Fuhr U
    Int J Clin Pharmacol Ther; 2000 Jan; 38(1):1-9. PubMed ID: 10667830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 genetic polymorphism in neonatal drug metabolism: role and practical consequences towards a new drug culture in neonatology.
    Fanni D; Ambu R; Gerosa C; Nemolato S; Castagnola M; Van Eyken P; Faa G; Fanos V
    Int J Immunopathol Pharmacol; 2014; 27(1):5-13. PubMed ID: 24674673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional distribution of drug-metabolizing enzyme activities in the liver and small intestine of cynomolgus monkeys.
    Nakanishi Y; Matsushita A; Matsuno K; Iwasaki K; Utoh M; Nakamura C; Uno Y
    Drug Metab Pharmacokinet; 2011 Jun; 26(3):288-94. PubMed ID: 21273732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogeny of drug metabolizing enzymes in the neonate.
    Blake MJ; Castro L; Leeder JS; Kearns GL
    Semin Fetal Neonatal Med; 2005 Apr; 10(2):123-38. PubMed ID: 15701578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.